Cefalea (II)migraña

  1. Yusta Izquierdo, Antonio
  2. Cubilla Salinas, M. A.
  3. Sánchez Palomo, M. J.
  4. Higes Pascual, Félix
Aldizkaria:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Argitalpen urtea: 2015

Zenbakien izenburua: Enfermedades del sistema nervioso (I): Cefaleas

Saila: 11

Zenbakia: 70

Orrialdeak: 4155-4166

Mota: Artikulua

DOI: 10.1016/S0304-5412(15)70894-2 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado

Garapen Iraunkorreko Helburuak

Laburpena

La migraña es la segunda cefalea primaria más frecuente después de la cefalea tensional. En ocasiones produce una alteración significativa de la calidad de vida de quien la padece. Es fundamental el diagnóstico y el tratamiento abortivo de la crisis como el tratamiento profiláctico de las mismas. Para un adecuado manejo habrá que individualizar el tratamiento dependiendo de la edad, del sexo y de otras comorbilidades que sufre el paciente migrañoso. Los tratamientos de las crisis de migraña, así como los profilácticos se deberán aplicar en las dosis necesarias o en las combinaciones sinérgicas, para mejorar la efectividad y evitar los efectos secundarios. Para el manejo se tendrá en cuenta no solo el tratamiento farmacológico, sino también la evitación de los factores desencadenantes o intensificadores. Hay determinados tipos de migraña de aparición menos frecuente, pero que si no se piensa en ellas pueden hacer sufrir al paciente un tratamiento equivocado, innecesario e incluso peligroso, así como la petición de pruebas innecesarias. Siempre ante un paciente migrañoso habrá que realizar una correcta anamnesis y exploración neurológica para detectar los signos o síntomas de alarma que nos hagan realizar una prueba de neuroimagen o la derivación a un neurólogo.

Erreferentzia bibliografikoak

  • Headache Classification Committee of the International Headache So-ciety. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 2004;24Supp1:1-160.
  • Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004;24Suppl2:2-7.
  • Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J, et al. Premonitory symptoms in migraine: an electronic diary study. Neu-rology. 2003;60(6):935-40.
  • Russell MB, Iversen HK, Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia. 1994;14:107-17.
  • Jensen K, Tfelt-Hansen P, Lauritzen M, Olesen J. Classic migraine. A prospective recording of symptoms. Acta Neurol Scand. 1986;73:359-62.
  • Sjaastad O, Torbjxrn AF, Sand T, Antonaci F. Unilaterality of headache in classic migraine. Cephalalgia. 1989;9:71-7.
  • Gupta R, Bhatia MS. A report of cranial autonomic symptoms in migrai-neurs. Cephalalgia. 2007;27:22-8.
  • Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-57.
  • Headache Classification Committee of the International Headache Soci-ety (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
  • Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology. 1994;44: S24-39.
  • Kors E, Haan J, Ferrari M. Migraine genetics. Curr Pain Headache Rep. 2003;7(3):212-7.
  • Wieser T, Pascual J, Oterino A, Soso M, Barmada M, Gardner KL. A novel locus for familial migraine on Xp22. Headache. 2010;50: 955-62.
  • Haan J, Kors EE, Vanmolkot KR, van den Maagdenberg AM, Frants RR, Ferrari MD. Migraine genetics: an update. Curr Pain Headache Rep. 2005;9(3):213-20.
  • Schurks M, Rist PM, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache. 2010a;50:588-99.
  • Lafreniere RG, Cader MZ, Poulin JF, Andres-Enguix I, Simo-neau M, Gupta N, et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010;16:1157-60.
  • Sánchez del Rio M, Reuter U. Migraine aura: new information on un-derlying mechanisms. Curr Opin Neurol. 2004;17(3):289-93.
  • Lauritzen M. Pathophysiology of the migraine aura. The spreading de-pression theory. Brain. 1994;117:199-210.
  • Lance JW. Fifty years of migraine research. Aust N Z J Med. 1988;18:311-7.
  • Fidan I, Yukjel S. The importance of cytokines, chemokines and nitric oxide in the pathophysiology of migraine. J Neuroimmunol. 2006;171: 184-8.
  • Lipton RB, Bigal ME, Diamond FF, Reed ML, Stewart WF. Mi-graine prevalence, disease burden, and the need for preventive the-rapy. Neurology. 2007;68:343-9.
  • Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med. 2002;346(4):257-70.
  • Kurth T. The association of migraine with ischemic stroke. Curr Neurol Neurosci Rep. 2010;10:133-9.
  • Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression. Is the association specific to migraine? Neurology. 2000;54:308-13.
  • Ottman R, Lipton RB. Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility? Neurology. 1996;47:918-24.
  • Odegard SS, Engstrom M, Sand T, Stovner LJ, Zwart JA, Hagen K. Associations between sleep disturbance and primary headaches: the third Nord-Trondelag Health Study. J Headache Pain. 2010;11: 197-206.
  • Frischberg BM. The utility of neuroimaging in the evaluation of heada-che in patients with normal neurologic examinations. Neurology. 1994;44:1191-7.
  • Cady RK, Dodick DW, Levine HL, Schreibes CP, Eross EJ, Setzen M, et al. Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc. 2005;80(7):908-16.
  • Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomized, cross-over trial. Cephalalgia. 2010;30: 829-37.
  • Silberstein SD. Practice parameter: evidence-based guidelines for migrai-ne headache (an evidence-based review). Neurology. 2000;55:754-62.
  • Becker WJ. Are the triptans for migraine therapy worth the cost? Can J Neurol Sci. 2000;27:111-5.
  • Lipton RB, Stewart WF, Sawyer J. Stratified care is a more effective stra-tegy than stepped care: results of a randomized clinical trial. Neurology. 2000;54Suppl3:A14.
  • Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5HT1b/d agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;538:1668-75.
  • Marin JC, Goadsby PC. Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Exp Opin Invest Drugs. 2010;19:555-61.
  • Silberstein SD, Holland S, Frietag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurolo-gy and the American Headache Society. Evidence-based guideline update. Pharmacologic treatment for episodic migraine prevention in adults: re-port of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17): 1337-45.
  • Dodick DW, Turkel CC, Degyrse RE, et al. Onabotulinumtoxi-nA for the treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50:921-36.
  • Rapoport AM, Bigal ME. Migraine preventive therapy: current and emerging treatment options. Neurol Sci. 2005;26Suppl2:111-20.
  • Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: a prospective study. Headache. 1997;37:203-10.
  • Evans EW, Lorber KC. Use of 5HT-1 agonist in pregnancy. Ann Phar-mocother. 2008;42:543-9.
  • Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40(3):224-30.
  • Benatar M, Ford CC. Familial hemiplegic migraine: more than just a headache. Neurology. 2005;64(4):592-3.
  • Barrett CF, Cao YQ, Tsien RW. Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. J Biol Chem. 2005; 280(25):24064-71.
  • Swoboda KJ, Kanavakis E, Xaidara A, Johnson JE, Leppert MF, Schlesin-ger-Massart MB, et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann Neurol. 2004;55(6): 884-7.
  • Kuhn WF, Kuhn SC, Daylida L. Basilar migraine. Eur J Emerg Med. 1997;4(1):33-8.
  • Olson AD, Li BU. The diagnostic evaluation of children with cyclic vo-miting: a cost-effectiveness assessment. J Pediatr. 2002;141(5):724-8.
  • D’Onofrio F, Cologno D, Buzzi MG, Petretta V, Caltagirone C, Casucci G, et al. Adult abdominal migraine: a new syndrome or sporadic feature of migraine headache? A case report. Eur J Neurol. 2006;13(1):85-8.
  • Blau JN, MacGregor EA. Retinal migraine. Lancet. 1993;342(8880):1185.
  • Levin M, Ward TN. Ophthalmoplegic migraine. Curr Pain Headache Rep. 2004;8(4):306-9.
  • Gladstone JP, Dodick DW. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcor-tical infarcts and leukoencephalopathy (CADASIL). Neurologist. 2005;11(1):19-29.
  • Milligan TA, Bromfield E. A case of “migralepsy”. Epilepsia. 2005;46Suppl10: 2-6.
  • Nezu A, Kimura S, Ohtsuki N, Tanaka M, Takebayashi S. Acute confusio-nal migraine and migrainous infarction in childhood. Brain Dev. 1997;19(2):148-51.
  • Headache Classification Committee of the International Headache So-ciety (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
  • Tomsak RL, Jergens PB. Benign recurrent transient monocular blindness: a possible variant of acephalgic migraine. Headache. 1987;27(2):66-9.
  • Graham JR, Wolf H. Mechanisms of migrain headache and action of er-gotamine tartrate. Arch. Neurol Psychiatr. 1938;39:737-63.
  • Olensen J, Friberg L, Skyhoj-Olesen T, Iversen HK, Lassen NA, Ander-sen AR, et al. Timing and topography of cerebral blood flow flow, aura and headache during migraine attacks. Ann Neurol. 1990;28:791-8.
  • Hargreaves RJ, Shepheard SL. Pathophysiology of migraine. New in-sights. Can J Neurol Sci. 1999;26Supl3:S12-19.
Datuen iturria: Dialnet